Efficacy of Novel Multimodality Pigment-Correcting Serum for Moderate to Severe Facial Hyperpigmentation, Including Melasma, in a 12-Week, Split-Face, Double-blind, Randomized Controlled Trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Nov. 25];7(2):s190. Available from: https://skin.dermsquared.com/skin/article/view/1992